Bank of Montreal’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.2M Buy
1,055,597
+271,330
+35% +$19.1M 0.03% 454
2025
Q4
$52.8M Buy
784,267
+368,651
+89% +$24.8M 0.02% 541
2025
Q3
$30.5M Sell
415,616
-78,793
-16% -$5.23M 0.01% 645
2025
Q2
$25.7M Buy
494,409
+69,698
+16% +$3.97M 0.01% 641
2025
Q1
$27.1M Sell
424,711
-45,070
-10% -$2.62M 0.01% 600
2024
Q4
$22.5M Sell
469,781
-155,919
-25% -$8M 0.01% 691
2024
Q3
$35.6M Buy
625,700
+100,769
+19% +$5.78M 0.02% 574
2024
Q2
$27.5M Buy
524,931
+5,501
+1% +$241K 0.01% 659
2024
Q1
$21.2M Buy
519,430
+14,888
+3% +$558K 0.01% 721
2023
Q4
$19.8M Buy
504,542
+51,943
+11% +$1.96M 0.01% 789
2023
Q3
$18.7M Sell
452,599
-32,619
-7% -$1.34M 0.01% 740
2023
Q2
$17.6M Buy
485,218
+12,873
+3% +$439K 0.01% 785
2023
Q1
$23.4M Buy
472,345
+156,372
+49% +$7.33M 0.01% 629
2022
Q4
$18.6M Sell
315,973
-115,423
-27% -$5.91M 0.01% 719
2022
Q3
$17.4K Buy
431,396
+411,341
+2,051% +$18.2M 0.01% 736
2022
Q2
$941 Buy
20,055
+1,510
+8% +$65.3K ﹤0.01% 2346
2022
Q1
$746K Buy
18,545
+498
+3% +$17.7K ﹤0.01% 2560
2021
Q4
$736K Sell
18,047
-100,702
-85% -$3.76M ﹤0.01% 2137
2021
Q3
$4.71M Sell
118,749
-2,444
-2% -$102K ﹤0.01% 1663
2021
Q2
$5.55M Buy
121,193
+303
+0.3% +$13.4K ﹤0.01% 1557
2021
Q1
$5.1M Sell
120,890
-56,256
-32% -$2.57M ﹤0.01% 1335
2020
Q4
$7.57M Sell
177,146
-31,562
-15% -$1.13M 0.01% 1173
2020
Q3
$5.53M Sell
208,708
-10,367
-5% -$289K ﹤0.01% 1141
2020
Q2
$6.13M Buy
219,075
+11,142
+5% +$251K 0.01% 1074
2020
Q1
$3.51M Buy
207,933
+9,686
+5% +$184K ﹤0.01% 1152
2019
Q4
$3.52M Buy
198,247
+104,125
+111% +$1.8M ﹤0.01% 1560
2019
Q3
$1.46M Buy
94,122
+10,079
+12% +$166K ﹤0.01% 1881
2019
Q2
$1.44M Buy
84,043
+83,783
+32,224% +$1.35M ﹤0.01% 1874
2019
Q1
$4K Sell
260
-1,751
-87% -$28.4K ﹤0.01% 4061
2018
Q4
$30K Buy
2,011
+896
+80% +$14.3K ﹤0.01% 3480
2018
Q3
$21K Sell
1,115
-31
-3% -$543 ﹤0.01% 3689
2018
Q2
$19K Sell
1,146
-1,404
-55% -$26.5K ﹤0.01% 3756
2018
Q1
$50K Hold
2,550
﹤0.01% 3228
2017
Q4
$51K Sell
2,550
-116,010
-98% -$2.13M ﹤0.01% 3260
2017
Q3
$2.06M Buy
118,560
+116,632
+6,049% +$1.58M ﹤0.01% 1604
2017
Q2
$25K Sell
1,928
-1,601
-45% -$21.4K ﹤0.01% 3447
2017
Q1
$45K Buy
3,529
+114
+3% +$1.44K ﹤0.01% 3117
2016
Q4
$41K Buy
3,415
+1,887
+123% +$20.7K ﹤0.01% 3177
2016
Q3
$18K Buy
1,528
+1,000
+189% +$10.2K ﹤0.01% 3382
2016
Q2
$5K Sell
528
-11,128
-95% -$110K ﹤0.01% 3724
2016
Q1
$110K Hold
11,656
﹤0.01% 2762
2015
Q4
$202K Buy
11,656
+10,558
+962% +$168K ﹤0.01% 2409
2015
Q3
$15K Buy
1,098
+418
+61% +$8.39K ﹤0.01% 3354
2015
Q2
$15K Sell
680
-30,500
-98% -$536K ﹤0.01% 3388
2015
Q1
$445K Buy
31,180
+1,180
+4% +$17K ﹤0.01% 1999
2014
Q4
$290K Hold
30,000
﹤0.01% 2323
2014
Q3
$273K Sell
30,000
-3,690
-11% -$35.1K ﹤0.01% 2377
2014
Q2
$332K Buy
33,690
+3,690
+12% +$31.3K ﹤0.01% 2290
2014
Q1
$381K Hold
30,000
﹤0.01% 2195
2013
Q4
$450K Hold
30,000
﹤0.01% 1862
2013
Q3
$331K Hold
30,000
﹤0.01% 1992
2013
Q2
$239K Buy
+30,000
New +$191K ﹤0.01% 2105

Other funds holding HALO

Bank of Montreal's HALO Position: Q1 2026 in Review

Bank of Montreal increased its Halozyme (HALO) stake by 35% in Q1 2026, buying an estimated $19.1M and bringing the position to 1,055,597 shares worth $68.2M. The position accounts for 0.03% of the portfolio, ranked #454.

Bank of Montreal first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Bank of Montreal held 1,055,597 shares of Halozyme worth $68.2M as of Q1 2026.
  • Bank of Montreal bought 271,330 Halozyme shares in Q1 2026, an estimated $19.1M.
  • Halozyme made up 0.03% of Bank of Montreal's portfolio in Q1 2026, its #454 holding.
  • Bank of Montreal first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.